ARTICLE | Company News
SurroMed, InterMune biomarker deal
March 4, 2003 8:00 AM UTC
SurroMed and ITMN partnered to identify biomarkers for use in ITMN's pulmonary and hepatic disease research programs. Under the deal, SurroMed will use its mass spectrometry technologies to analyze cl...